Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae , induces apoptosis in some human cell lines
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The cytotoxic effect of microcin E492, a low-molecular-mass channel-forming bacteriocin (7,887 Da) produced by a strain of Klebsiella pneumoniae , was characterized in HeLa cells. At low (5 μg/ml) and intermediate (10 μg/ml) concentrations, microcin E492 induced biochemical and morphological changes typical of apoptosis, such as cell shrinkage, DNA fragmentation, extracellular exposure of phosphatidylserine, caspase activation, and loss of mitochondrial membrane potential. Treatment with zVAD-fmk, a general caspase inhibitor, completely blocked the cytotoxic effect of this bacteriocin. At higher microcin concentrations (>20 μg/ml) a necrotic phenotype was observed. Induction of apoptosis by microcin E492 was associated with the release of calcium from intracellular stores, probably after microcin-triggered ion channel formation. Microcin E492 also presented a cytotoxic effect on Jurkat and RJ2.25 cells, but had no effect on KG-1 cells nor on a primary culture of human tonsil endothelial cells, suggesting that there is a specific interaction of the bacteriocin with components of the target cell surface. This report describes a bacteriocin that has the capacity to induce apoptosis in human cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacteriocins of gram-positive bacteria
Jack, R. W., Tagg, J. R., & Ray, B. (1995) · Microbiological Reviews · doi:10.1128/mr.59.2.171-200.1995 · Cited by 2,711
Cited by
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
Simons, A., Alhanout, K., & Duval, R. E. (2020) · Microorganisms · doi:10.3390/microorganisms8050639 · Cited by 547
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
Soltani, S., Hammami, R., Cotter, P. D., Rebuffat, S., Said, L. B., Gaudreau, H., Bédard, F., Biron, E., Drider, D., & Fliss, I. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa039 · Cited by 544
Inositol 1,4,5-Trisphosphate Receptors as Signal Integrators
Patterson, R. L., Boehning, D., & Snyder, S. H. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.161303 · Cited by 441
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein
Hetz, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg537 · Cited by 396
Self-citationMicrocins, gene-encoded antibacterial peptides from enterobacteria
Duquesne, S., Destoumieux-Garzón, D., Peduzzi, J., & Rebuffat, S. (2007) · Natural Product Reports · doi:10.1039/b516237h · Cited by 390
Mapping the Evolution of Hypervirulent Klebsiella pneumoniae
Struve, C., Roe, C. C., Stegger, M., Stahlhut, S. G., Hansen, D. S., Engelthaler, D. M., Andersen, P. S., Driebe, E. M., Keim, P., & Krogfelt, K. A. (2015) · mBio · doi:10.1128/mbio.00630-15 · Cited by 368
Diversity, biogenesis and function of microbial amyloids
Blanco, L. P., Evans, M. L., Smith, D. R., Badtke, M. P., & Chapman, M. R. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.005 · Cited by 320
“Microcin E492 has been shown to trigger apoptosis in some human cell lines, reminiscent of the toxic effect observed for disease-associated preamyloid oligomers [71].”
BackgroundMeade, E., Slattery, M. A., & Garvey, M. (2020) · Antibiotics · doi:10.3390/antibiotics9010032 · Cited by 320
O'Shea, E. F., Cotter, P. D., Stanton, C., Ross, R. P., & Hill, C. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.05.025 · Cited by 305
“…bacteria considering that several 546 have exhibited inhibitory activity towards human cells (Booth et al., 1996; Chumchalova & 547 Smarda, 2003; Hetz et al., 2002; Lagos et al., 2009; Lancaster et al., 2007; Smarda, 1983; 548 Watanabe & Saito, 1980) although it should be pointed out that as…”
BackgroundBacteriocins as Potential Anticancer Agents
Kaur, S., & Kaur, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00272 · Cited by 269
Hetz, C., Vitte, P.-A., Bombrun, A., Rostovtseva, T. K., Montessuit, S., Hiver, A., Schwarz, M. K., Church, D. J., Korsmeyer, S. J., Martinou, J.-C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505843200 · Cited by 176
Self-citationColicins and Microcins: The Next Generation Antimicrobials
Gillor, O., Kirkup, B. C., & Riley, M. A. (2004) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(04)54005-4 · Cited by 159
Bacteriocins: Perspective for the development of novel anticancer drugs
Baindara, P., Korpole, S., & Grover, V. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9420-8 · Cited by 139
Microbial functional amyloids serve diverse purposes for structure, adhesion and defence
Shanmugam, N., Baker, M. O. D. G., Ball, S. R., Steain, M., Pham, C. L. L., & Sunde, M. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00526-1 · Cited by 75
Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?
Dicks, L. M. T., & Vermeulen, W. (2022) · Microorganisms · doi:10.3390/microorganisms10091733 · Cited by 25
Metadata
- Authors
- Hetz, C., Bono, M. R., Barros, L. F., & Lagos, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-03-05
- Volume
- 99
- Issue
- 5
- Pages
- 2696-2701
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2042493764
- Cited by
- 157
- References
- 1
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.